Department of Neuroscience and Experimental Therapeutics, College of Medicine, Texas A&M University Health Science Center, Bryan, Texas.
Department of Cellular and Integrative Physiology, University of Texas Health Science Center San Antonio, San Antonio, Texas.
Epilepsia. 2019 Apr;60(4):730-743. doi: 10.1111/epi.14693. Epub 2019 Mar 20.
Sex differences are evident in the antiseizure activity of neurosteroids; however, the potential mechanisms remain unclear. In this study, we sought to determine whether differences in target extrasynaptic δ-subunit γ-aminobutyric acid type A (GABA-A) receptor expression and function underlie the sex differences in seizure susceptibility and the antiseizure activity of neurosteroids.
Sex differences in seizure susceptibility and protective activity of three distinct neurosteroids-allopregnanolone (AP), androstanediol (AD), and ganaxolone-were evaluated in the pilocarpine model of status epilepticus (SE) and kindling seizure test in mice. Immunocytochemistry was used for δGABA-A receptor expression analysis, and patch-clamp recordings in brain slices evaluated its functional currents.
Sex differences were apparent in kindling epileptogenic seizures, with males exhibiting a faster progression to a fully kindled state. Neurosteroids AP, AD, or ganaxolone produced dose-dependent protection against SE and acute partial seizures. However, female mice exhibited strikingly enhanced sensitivity to the antiseizure activity of neurosteroids compared to males. Sex differences in neurosteroid protection were unrelated to pharmacokinetic factors, as plasma levels of neurosteroids associated with seizure protection were similar between sexes. Mice lacking extrasynaptic δGABA-A receptors did not exhibit sex differences in neurosteroid protection. Consistent with a greater abundance of extrasynaptic δGABA-A receptors, AP produced a significantly greater potentiation of tonic currents in dentate gyrus granule cells in females than males; however, such enhanced AP sensitivity was diminished in δGABA-A receptor knockout female mice.
Neurosteroids exhibit greater antiseizure potency in females than males, likely due to a greater abundance of extrasynaptic δGABA-A receptors that mediate neurosteroid-sensitive tonic currents and seizure protection. These findings indicate the potential to develop personalized gender-specific neurosteroid treatments for SE and epilepsy in men and women, including catamenial epilepsy.
神经甾体在抗惊厥活性方面存在性别差异;然而,潜在机制尚不清楚。本研究旨在确定突触外 δ 亚单位 γ-氨基丁酸 A 型(GABA-A)受体表达和功能的差异是否是导致易发性癫痫和神经甾体抗惊厥活性的性别差异的基础。
在匹罗卡品癫痫持续状态(SE)模型和点燃性癫痫发作测试中,评估了三种不同神经甾体(别孕烯醇酮、雄烷二醇和 ganaxolone)的易发性癫痫和保护活性的性别差异。免疫细胞化学用于 δGABA-A 受体表达分析,脑片膜片钳记录评估其功能电流。
在点燃性癫痫发作中存在明显的性别差异,雄性表现出更快地进入完全点燃状态。神经甾体 AP、AD 或 ganaxolone 对 SE 和急性部分性癫痫发作呈剂量依赖性保护。然而,与雄性相比,雌性对神经甾体的抗惊厥活性表现出惊人的敏感性增强。神经甾体保护的性别差异与药代动力学因素无关,因为与癫痫保护相关的神经甾体的血浆水平在两性之间相似。缺乏突触外 δGABA-A 受体的小鼠在神经甾体保护方面没有表现出性别差异。与突触外 δGABA-A 受体的丰度更高一致,AP 在雌性小鼠的齿状回颗粒细胞中产生明显更大的紧张性电流增强;然而,这种增强的 AP 敏感性在 δGABA-A 受体敲除的雌性小鼠中减弱。
神经甾体在女性中比男性具有更强的抗惊厥效力,这可能是由于更多的突触外 δGABA-A 受体介导了神经甾体敏感的紧张性电流和癫痫保护。这些发现表明,有可能针对男性和女性的 SE 和癫痫,包括月经性癫痫,开发个性化的性别特异性神经甾体治疗方法。